ArticleTherapeutic advances in medical oncology2022

A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinoma.

Louisa Hempel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.